Showing results (371-380 of 701) with videos related to

Sort By:
Pageof 71
Experimental and Clinical Psychopharmacology|April 6, 2016
Comparison of nicotine dependence indicators in predicting quitting among pregnant smokersAllison N Kurti, Danielle R Davis, Joan M Skelly, et al.
Frontiers in Psychiatry|July 9, 2021
Ecological Momentary Mood, Resilience, and Mental Health Status as Predictors of Quality of Life Among Young Adults Under Stress: A Structural Equation Modeling AnalysisRachel-Tzofia Sinvani, Haya Fogel-Grinvald, Anat Afek, et al.
Nephrology (Carlton, Vic.)|November 9, 2012
Haemoglobin variability in the early post-transplant period: association with graft survival and mortalityBenaya Rozen-Zvi, Binjamin Ben-Avraham, Shira Schneider, et al.
British Journal of Haematology|November 20, 2002
Long-term ex vivo expansion of human fetal liver primitive haematopoietic progenitor cells in stroma-free culturesRowayda Peters, Serge Leyvraz, Eveline Faes-Van't Hull, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2009
Dose reduction of epoetin-alpha in the prevention of chemotherapy-induced anaemiaFrançois Lüthi, Miklos Pless, Serge Leyvraz, et al.
Revue Medicale Suisse|October 27, 2017
[Assisted reproductive technology : strategies of elective single embryo transfer]Smaranda Gazdaru, Anna Surbone, Patrice Mathevet, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I studyVerena Voelter, Roger Stupp, Maurice Matter, et al.
Helvetica Chirurgica Acta|December 1, 1989
[Epidermoid carcinoma of the esophagus: preliminary results of combined treatment]M Merlini, S Gabellon, W Elbaze, et al.
Journal of Biomechanics|September 1, 1995
Experimental and mathematical methods for representing relative surface elongation of the ACLD P Pioletti, J H Heegaard, R L Rakotomanana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)S Leyvraz, M Bacchi, T Cerny, et al.
Pageof 71